Sanofi

SARCLISA

Manufacturer:

Sanofi

Sarclisa HCPCS:

J9227

HCPCS Code Descriptor:

Injection, isatuximab-irfc, 10 mg

Category:

J Code

Sarclisa NDCs:

00024-0656-01, 00024-0654-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Sarclisa:

SARCLISA is an Oncology drug manufactured by Sanofi and administered via the Intravenous route of administration. The J Code: J9227 is aligned to the drug SARCLISA.

ACCESS PRICING AND MORE BY REGISTERING

J9227 Added Date:

October 1, 2020

J9227 Effective Date:

October 1, 2020

J9227 Termination Date:

HCPCS Active

Sarclisa billing and coding information can be found through Sanofi at the link below:
Sarclisa patient assistance information can be found through Sanofi’s CareASSIST at the URL: https://www.sanoficareassist.com/
SARCLISA prescribing information can be found at the link below:
Information regarding SARCLISA’s side effects can be found at MedlinePlus